China Resources Medical Holdings Company Limited (HKG:1515)
Hong Kong
· Delayed Price · Currency is HKD 3.620
-0.050 (-1.36%)
Apr 28, 2025, 4:08 PM HKT
HKG:1515 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 9,855 | 10,108 | 7,901 | 4,447 | 2,751 | Upgrade
|
| Revenue Growth (YoY) | -2.50% | 27.92% | 77.66% | 61.69% | 30.04% | Upgrade
|
| Cost of Revenue | 8,045 | 8,202 | 6,595 | 3,514 | 2,114 | Upgrade
|
| Gross Profit | 1,810 | 1,906 | 1,306 | 933.56 | 636.51 | Upgrade
|
| Selling, General & Admin | 1,049 | 973.5 | 828.19 | 488.23 | 337.97 | Upgrade
|
| Other Operating Expenses | 7.92 | 0.18 | -8.06 | - | - | Upgrade
|
| Operating Expenses | 1,057 | 1,053 | 856.22 | 565.88 | 358.4 | Upgrade
|
| Operating Income | 752.69 | 852.24 | 449.6 | 367.68 | 278.11 | Upgrade
|
| Interest Expense | -75.28 | -114.86 | -55.9 | -16.23 | -17.02 | Upgrade
|
| Interest & Investment Income | 17.8 | 89.2 | 96.6 | 80.24 | 82.55 | Upgrade
|
| Earnings From Equity Investments | 98.6 | 90.78 | 88.07 | 83.55 | 34.97 | Upgrade
|
| Currency Exchange Gain (Loss) | -1.19 | -77.69 | -158.88 | 26.8 | 44.31 | Upgrade
|
| Other Non Operating Income (Expenses) | 103.61 | 23.96 | 101.05 | -20.32 | 14.21 | Upgrade
|
| EBT Excluding Unusual Items | 896.24 | 863.63 | 520.53 | 521.72 | 437.13 | Upgrade
|
| Impairment of Goodwill | - | -141.02 | -108.32 | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -14.23 | -16.52 | 5.63 | -240.1 | -25.14 | Upgrade
|
| Gain (Loss) on Sale of Assets | -11.19 | -2.39 | 5.41 | - | - | Upgrade
|
| Asset Writedown | -32.15 | -210.79 | -0.51 | -11.15 | -3.59 | Upgrade
|
| Other Unusual Items | - | - | 0.2 | - | 9.78 | Upgrade
|
| Pretax Income | 838.67 | 492.92 | 422.94 | 270.48 | 418.19 | Upgrade
|
| Income Tax Expense | 166.92 | 165.03 | 94.66 | -155.39 | 97.86 | Upgrade
|
| Earnings From Continuing Operations | 671.75 | 327.89 | 328.28 | 425.86 | 320.32 | Upgrade
|
| Minority Interest in Earnings | -105.87 | -70.21 | -62.43 | -7.95 | -10.19 | Upgrade
|
| Net Income | 565.88 | 257.68 | 265.86 | 417.92 | 310.13 | Upgrade
|
| Net Income to Common | 565.88 | 257.68 | 265.86 | 417.92 | 310.13 | Upgrade
|
| Net Income Growth | 119.60% | -3.08% | -36.38% | 34.75% | -20.66% | Upgrade
|
| Shares Outstanding (Basic) | 1,264 | 1,264 | 1,262 | 1,256 | 1,256 | Upgrade
|
| Shares Outstanding (Diluted) | 1,264 | 1,264 | 1,262 | 1,264 | 1,261 | Upgrade
|
| Shares Change (YoY) | - | 0.18% | -0.14% | 0.21% | 0.50% | Upgrade
|
| EPS (Basic) | 0.45 | 0.20 | 0.21 | 0.33 | 0.25 | Upgrade
|
| EPS (Diluted) | 0.45 | 0.20 | 0.21 | 0.33 | 0.25 | Upgrade
|
| EPS Growth | 123.79% | -4.76% | -36.36% | 33.64% | -20.34% | Upgrade
|
| Free Cash Flow | - | 708.44 | 397.31 | 512 | 434.14 | Upgrade
|
| Free Cash Flow Per Share | - | 0.56 | 0.32 | 0.41 | 0.34 | Upgrade
|
| Dividend Per Share | 0.132 | 0.060 | 0.033 | 0.098 | 0.074 | Upgrade
|
| Dividend Growth | 120.00% | 81.82% | -66.33% | 32.43% | -17.78% | Upgrade
|
| Gross Margin | 18.37% | 18.85% | 16.53% | 20.99% | 23.14% | Upgrade
|
| Operating Margin | 7.64% | 8.43% | 5.69% | 8.27% | 10.11% | Upgrade
|
| Profit Margin | 5.74% | 2.55% | 3.36% | 9.40% | 11.28% | Upgrade
|
| Free Cash Flow Margin | - | 7.01% | 5.03% | 11.51% | 15.78% | Upgrade
|
| EBITDA | 1,312 | 1,411 | 882.74 | 527.91 | 372.58 | Upgrade
|
| EBITDA Margin | 13.31% | 13.96% | 11.17% | 11.87% | 13.54% | Upgrade
|
| D&A For EBITDA | 559.11 | 559.11 | 433.14 | 160.23 | 94.47 | Upgrade
|
| EBIT | 752.69 | 852.24 | 449.6 | 367.68 | 278.11 | Upgrade
|
| EBIT Margin | 7.64% | 8.43% | 5.69% | 8.27% | 10.11% | Upgrade
|
| Effective Tax Rate | 19.90% | 33.48% | 22.38% | - | 23.40% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.